The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Sarcopenic obesity in ageing: cardiovascular outcomes and mortality
Abstract
Obesity is a major public health issue with prevalence increasing worldwide. Obesity is a well-established risk factor for CVD and mortality in adult populations. However, the impact of being overweight or obese in the elderly on CVD and mortality is controversial. Some studies even suggest that overweight and obesity, measured by BMI, are apparently associated with a decreased mortality risk (known as the obesity paradox). Ageing is associated with an increase in visceral fat and a progressive loss of muscle mass. Fat mass is positively associated and lean mass is negatively associated with risk of mortality. Therefore, in older adults BMI is not a good indicator of obesity. Sarcopenia has been defined as the degenerative loss of muscle mass, quality and strength with age and is of major concern in ageing populations. Sarcopenia has previously been associated with increased risks of metabolic impairment, cardiovascular risk factors, physical disability and mortality. It is possible for sarcopenia to co-exist with obesity, and sarcopenic obesity is a new class of obesity in older adults who have high adiposity levels together with low muscle mass, quality or strength. Therefore, sarcopenia with obesity may act together to increase their effect on metabolic disorders, CVD and mortality. This review will discuss the available evidence for the health implications of sarcopenic obesity on CVD and mortality in older adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sarcopenic obesity significantly increases the risk of cardiovascular risk factors including insulin resistance (IR), metabolic syndrome, and adverse glycolipid metabolism (16, 42–44), even in the context of divergent comorbidities such as cancer and peritoneal dialysis (45, 46).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [42]
In the citing paper
“Sarcopenic obesity has been so far identified through various definitions and diagnostic constructs, but it has been consistently demonstrated to be a strong and independent risk factor for frailty, comorbidities and mortality in various highly prevalent disease conditions, as well as for mortality in the general and especially in the older population [17-19].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [18]
In the citing paper
“Nevertheless, up to 8-fold increased risk of metabolic syndrome in individuals classified as having sarcopenic obesity has been reported along with increased risk for other cardiovascular/metabolic diseases (14).”
From Body composition in male lifelong trained strength, sprint and endurance athletes and healthy age-matched controls (2023) · cites this paper as [14]
In the citing paper
“It is important to remember that sarcopenic obesity can occur at any age, and that excess fat and low muscle mass may act synergistically to influence daily physical activity/energy expenditure and increase the risk of cardiovascular comorbidities across adulthood and subsequently premature mortality (14).”
From Body composition in male lifelong trained strength, sprint and endurance athletes and healthy age-matched controls (2023) · cites this paper as [14]
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 2×
“In 2010, The European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition to assist in case finding in older adults(49).”
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Levesque, R. J. R. (2017) · Encyclopedia of Adolescence · doi:10.1007/978-3-319-32132-5_447-2 · Cited by 4,021
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“Sarcopenia was originally defined by Baumgartner et al.(19) as appendicular skeletal muscle mass two SD below”
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Janssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 1×
“Janssen et al.(48) developed an alternative sarcopenia definition of skeletal muscle mass measured by BIA.”
The Epidemiology of Obesity: A Big Picture
Hruby, A., & Hu, F. B. (2015) · PharmacoEconomics · doi:10.1007/s40273-014-0243-x · Cited by 2,916
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 1×
“In 2014, an alternative and more specific sarcopenia definition was recommended by the Foundation for the National Institutes of Health Sarcopenia Project; appendicular lean mass cut-points adjusted for BMI (<0·789 for men;<0·512 for women) and for grip strength cut-points (<26 kg for men; <16 kg for women)(50).”
Research works printed but not linked: 2
- 2011, Healthy Lives, Healthy People: A Call to Action on Obesity in England
- 10.1093/ajcn/82.2.428 · DOI · Paper page
Cited by
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
Wei, S., Nguyen, T. T., Zhang, Y., Ryu, D., & Gariani, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185221 · Cited by 291
Ten things to know about ten cardiovascular disease risk factors
Bays, H. E., Taub, P. R., Epstein, E., Michos, E. D., Ferraro, R. A., Bailey, A. L., Kelli, H. M., Ferdinand, K. C., Echols, M. R., Weintraub, H., et al. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100149 · Cited by 274
Sarcopenia and Sarcopenic Obesity and Mortality Among Older People
Benz, E., Pinel, A., Guillet, C., Capel, F., Pereira, B., De Antonio, M., Pouget, M., Cruz-Jentoft, A. J., Eglseer, D., Topinkova, E., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3604 · Cited by 261
Metadata
- Authors
- Atkins, J. L., & Wannamathee, S. G.
- Affiliations
- University of Exeter (GB)
- Corresponding author
- Atkins, Janice L.
- ORCID
- Atkins, Janice L.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2020-06-18
- Volume
- 124
- Issue
- 10
- Pages
- 1102-1113
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W3036595750
- Cited by
- 187
- References
- 91
- Citations by year
- 2026: 16 · 2025: 39 · 2024: 42 · 2023: 36 · 2022: 30 · 2021: 21 · 2020: 2
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- British Journal Of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (SPCR-031)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- sarcopenic obesity, sarcopenia, aging, cardiovascular disease, mortality, obesity paradox, body mass index, visceral fat, lean body mass, muscle mass, older adults, adiposity
- MeSH terms
- Aged, Aged, 80 and over, Aging, Body Composition, Cardiovascular Diseases, Female, Humans, Inflammation, Male, Middle Aged, Obesity, Risk Factors, Body Mass Index, Adiposity, Overweight, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sarcopenic obesity in ageing: cardiovascular outcomes and mortality. https://app.cochat.ai/papers/10.1017/s0007114520002172
- The paper
- Atkins, J. L., & Wannamathee, S. G. (2020). Sarcopenic obesity in ageing: cardiovascular outcomes and mortality. British Journal of Nutrition. https://doi.org/10.1017/s0007114520002172
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.